Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06886256 · ClinicalTrials.gov registry record · NA

Prehabilitation for Kidney Transplant Candidates

A NA study of Frailty and Kidney Transplantation, sponsored by The Methodist Hospital Research Institute.

Recruiting
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT06886256 is a NA study of Frailty and Kidney Transplantation that is actively recruiting participants, run by The Methodist Hospital Research Institute. The registered enrollment target is 15 participants, below the 1,506-participant average among 48 other Frailty trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06886256, a NA study of Frailty and Kidney Transplantation, is actively recruiting participants, sponsored by The Methodist Hospital Research Institute.

RECRUITING
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

This interventional trial seeks to determine the feasibility of wearable sensors to provide data from patients while undergoing supervised exercise.

Interventions

  • DEVICE Empatica EmbracePlus
  • DEVICE Polar H10 Heart Rate Monitor
  • DEVICE Apple Watch Ultra 2

Study Locations (1)

Texas

  • Houston Methodist Hospital System - Houston

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2025-03-26
Est. Completion 2025-09-30
Phase NA

What the Registry Record Tells You About NCT06886256

The ClinicalTrials.gov registry entry for NCT06886256 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,506-participant average among 48 other Frailty trials with a reported enrollment target (99% lower). The listed sponsor is The Methodist Hospital Research Institute, which has 126 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Frailty appearing as the primary indexed condition, and to 3 interventions - of which Empatica EmbracePlus is the first listed.

NCT06886256 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06886256 about?

NCT06886256 is a clinical study titled "Prehabilitation for Kidney Transplant Candidates". This interventional trial seeks to determine the feasibility of wearable sensors to provide data from patients while undergoing supervised exercise.

What is the current status of trial NCT06886256?

This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2025-03-26. Estimated completion is 2025-09-30.

What conditions does trial NCT06886256 study?

This clinical trial studies the following conditions: Frailty, Kidney Transplantation, Chronic Kidney Insufficiency.

What interventions are being tested in trial NCT06886256?

The interventions under investigation include: Empatica EmbracePlus (DEVICE), Polar H10 Heart Rate Monitor (DEVICE), Apple Watch Ultra 2 (DEVICE).

Who is sponsoring clinical trial NCT06886256?

This trial is sponsored by The Methodist Hospital Research Institute, which has 126 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06886256 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Frailty

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.